Laser Technology Advancements in the Treatment of Benign Prostatic Hypertrophy.

IF 2.5 2区医学 Q2 UROLOGY & NEPHROLOGY

Current Urology Reports Pub Date : 2024-04-01 Epub Date: 2024-02-13 DOI:10.1007/s11934-024-01197-6

David C Dalton, T Max Shelton, Marcelino Rivera

{"title":"Laser Technology Advancements in the Treatment of Benign Prostatic Hypertrophy.","authors":"David C Dalton, T Max Shelton, Marcelino Rivera","doi":"10.1007/s11934-024-01197-6","DOIUrl":null,"url":null,"abstract":"Purpose of review: Lasers have had a significant impact on the treatment of benign prostatic hypertrophy. This article attempts to distill the advancements in laser technology for the treatment of benign prostatic hypertrophy (BPH) into key and understandable points to help make this topic more accessible to urologists.Recent findings: The holmium:yttrium-aluminum-garnet (YAG) laser, one of the most significant lasers in the field of urology, has recently been improved with pulse modulating technology (Moses™ technology). New thulium:YAG technology allows both pulsed and continuous wave modes. The thulium fiber laser is one of the newer lasers to come to market and has been shown to have effective and safe outcomes. GreenLight™ lasers are predominantly used in photovaporization procedures and have also been studied extensively, although less in recent years. The modern urologist is fortunate to have many high-quality lasers and a wide variety of surgical techniques to choose from when treating BPH. Understanding the basic laser principles and applications will help urologists to select the best treatment options for their patients with BPH.","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"71-78"},"PeriodicalIF":2.5000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Urology Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11934-024-01197-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: Lasers have had a significant impact on the treatment of benign prostatic hypertrophy. This article attempts to distill the advancements in laser technology for the treatment of benign prostatic hypertrophy (BPH) into key and understandable points to help make this topic more accessible to urologists.

Recent findings: The holmium:yttrium-aluminum-garnet (YAG) laser, one of the most significant lasers in the field of urology, has recently been improved with pulse modulating technology (Moses™ technology). New thulium:YAG technology allows both pulsed and continuous wave modes. The thulium fiber laser is one of the newer lasers to come to market and has been shown to have effective and safe outcomes. GreenLight™ lasers are predominantly used in photovaporization procedures and have also been studied extensively, although less in recent years. The modern urologist is fortunate to have many high-quality lasers and a wide variety of surgical techniques to choose from when treating BPH. Understanding the basic laser principles and applications will help urologists to select the best treatment options for their patients with BPH.

查看原文本刊更多论文

治疗良性前列腺肥大的激光技术进展。

审查目的：激光对良性前列腺肥大的治疗产生了重大影响。本文试图将激光技术在治疗良性前列腺肥大（BPH）方面的进展归纳为一些关键且易于理解的要点，以帮助泌尿科医生更容易理解这一主题：钬：钇铝石榴石（YAG）激光器是泌尿外科领域最重要的激光器之一，最近通过脉冲调制技术（Moses™技术）对其进行了改进。新的铥 YAG 技术允许脉冲和连续波两种模式。铥光纤激光器是市场上较新的激光器之一，已被证明具有有效和安全的效果。GreenLight™ 激光器主要用于光汽化手术，虽然近年来研究较少，但也得到了广泛的研究。现代泌尿科医生很幸运，在治疗良性前列腺增生症时有许多高质量的激光和多种手术技术可供选择。了解激光的基本原理和应用有助于泌尿科医生为良性前列腺增生患者选择最佳治疗方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Urology Reports UROLOGY & NEPHROLOGY-

CiteScore

4.60

自引率

3.80%

发文量

期刊介绍： This journal intends to review the most important, recently published findings in the field of urology. By providing clear, insightful, balanced contributions by international experts, the journal elucidates current and emerging approaches to the care and prevention of urologic diseases and conditions. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as benign prostatic hyperplasia, erectile dysfunction, female urology, and kidney disease. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.